CARN Practice Exam – Comprehensive Study Guide 2026

The correct answer is Parkinson's disease. This connection arises from the fact that MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is a neurotoxin that affects the brain in a manner similar to that of Parkinson’s disease. When MPTP is metabolized in the body, it produces a byproduct that directly damages dopamine-producing neurons within the substantia nigra region of the brain, which is critical for motor control.

Individuals who inadvertently consume drugs laced with MPTP may experience symptoms akin to those of Parkinson's disease, such as tremors, rigidity, and bradykinesia (slowness of movement). The resemblance is so pronounced that MPTP exposure is often studied as a model for Parkinson’s disease in research settings.

Understanding the link between MPTP and Parkinson's disease emphasizes the dangers associated with synthetic opioids and drugs contaminated with harmful substances. The ramifications of such contamination extend beyond the immediate effects of substance use, highlighting the potential for long-term neurological consequences.